Press Releases
CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.
May 31, 2023
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
February 27, 2023
California stem cell and gene therapy agency investing in clinical trial for knee osteoarthritis
California stem cell and gene therapy agency investing in clinical trial for knee osteoarthritis
December 15, 2022
Stem Cell & Gene Therapy Agency Funds Clinical Trial to Make Cancer Therapy Safer and Less Toxic
Stem Cell & Gene Therapy Agency Funds Clinical Trial to Make Cancer Therapy Safer and Less Toxic
November 29, 2022
Stem Cell and Gene Therapy Agency Funds Clinical Trials Targeting Solid Tumors, and to Make Kidney Transplants Easier for Patients
Stem Cell and Gene Therapy Agency Funds Clinical Trials Targeting Solid Tumors, and to Make Kidney Transplants Easier for Patients
October 3, 2022
Judy Chou, Ph.D., Appointed to Governing Board of California’s Stem Cell & Gene Therapy Agency
Judy Chou, Ph.D., Appointed to Governing Board of California’s Stem Cell & Gene Therapy Agency
September 29, 2022
State Stem Cell & Gene Therapy Agency Sets up Support Program to Help Patients Participate in Clinical Trials
State Stem Cell & Gene Therapy Agency Sets up Support Program to Help Patients Participate in Clinical Trials
September 20, 2022
Stem Cell and Gene Therapy Agency Funds Clinical Trial for a Functional Cure for HIV
Stem Cell and Gene Therapy Agency Funds Clinical Trial for a Functional Cure for HIV
July 28, 2022
CIRM Board Approves Funding for Clinical Trial Targeting Painful Scarring of the Urethra
CIRM Board Approves Funding for Clinical Trial Targeting Painful Scarring of the Urethra
June 23, 2022
Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
April 19, 2022
Stem Cell Agency Invests in Therapy Using Killer Cells to Target Colorectal, Breast and Ovarian Cancers
Stem Cell Agency Invests in Therapy Using Killer Cells to Target Colorectal, Breast and Ovarian Cancers
February 14, 2022
CIRM-Funded Study Helping Babies Battle a Deadly Immune Disorder Gets Boost from FDA
CIRM-Funded Study Helping Babies Battle a Deadly Immune Disorder Gets Boost from FDA
January 27, 2022
Stem Cell Agency Board Approves Two Early-Stage Research Programs Targeting Cartilage Damage
Stem Cell Agency Board Approves Two Early-Stage Research Programs Targeting Cartilage Damage
January 24, 2022
California Institute for Regenerative Medicine and the Davos Alzheimer’s Collaborative Release a Statement of Interest to Advance Brain Research
California Institute for Regenerative Medicine and the Davos Alzheimer’s Collaborative Release a Statement of Interest to Advance Brain Research
December 14, 2021
Stem Cell Agency Board Approves Roadmap for Next Five Years; Invests $5M in High School Internships
Stem Cell Agency Board Approves Roadmap for Next Five Years; Invests $5M in High School Internships
September 23, 2021
Stem Cell Agency Funds Clinical Trial Targeting Blood Cancers in Children and Young Adults
Stem Cell Agency Funds Clinical Trial Targeting Blood Cancers in Children and Young Adults
July 20, 2021
Board Funds Fifteen Bridges to Stem Cell Research and Therapy Programs Across California and New Sickle Cell Disease Trial
Board Funds Fifteen Bridges to Stem Cell Research and Therapy Programs Across California and New Sickle Cell Disease Trial
June 24, 2021
CIRM Adds Five New Hires, including VP Scientific Programs and a Decorated Veteran, to Build Out Its World Class Team
CIRM Adds Five New Hires, including VP Scientific Programs and a Decorated Veteran, to Build Out Its World Class Team
May 28, 2021
Statement from Dr. Maria Millan on the News of Orchard Returning the Treatment for ADA-SCID to UCLA
Statement from Dr. Maria Millan on the News of Orchard Returning the Treatment for ADA-SCID to UCLA
May 14, 2021
Industry Executive Kevin Marks joins CIRM as General Counsel during the Agency’s first wave of strategic growth
Industry Executive Kevin Marks joins CIRM as General Counsel during the Agency’s first wave of strategic growth
May 12, 2021
Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients
Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients
May 11, 2021
New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder.
New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder.
December 14, 2020
CIRM-Funded Project Targeting Sickle Cell Disease Gets Green Light for Clinical Trial
CIRM-Funded Project Targeting Sickle Cell Disease Gets Green Light for Clinical Trial